Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
8.52
-0.26 (-2.96%)
Nov 21, 2024, 4:00 PM EST - Market closed
Ocular Therapeutix Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1,339 | 492 | 216 | 534 | 1,559 | 190 | |
| Market Cap Growth | 444.20% | 127.16% | -59.47% | -65.74% | 720.77% | 15.59% | |
| Enterprise Value | 1,028 | 464 | 155 | 413 | 1,546 | 183 | |
| Last Close Price | 8.78 | 4.46 | 2.81 | 6.97 | 20.70 | 3.95 | |
| PS Ratio | 19.63 | 8.41 | 4.20 | 12.27 | 89.57 | 44.93 | |
| PB Ratio | 3.91 | 5.39 | 6.12 | 6.07 | 20.48 | -52.32 | |
| P/TBV Ratio | 3.85 | 5.39 | 6.12 | 6.07 | 20.48 | - | |
| EV/Sales Ratio | 16.74 | 7.94 | 3.01 | 9.50 | 88.85 | 43.26 | |
| Debt / Equity Ratio | 0.21 | 0.92 | 1.82 | 0.67 | 0.77 | -16.35 | |
| Asset Turnover | 0.19 | 0.29 | 0.29 | 0.19 | 0.10 | 0.06 | |
| Inventory Turnover | 46.60 | 31.01 | 35.98 | 44.46 | 28.56 | 74.15 | |
| Quick Ratio | 12.58 | 6.36 | 3.94 | 7.04 | 9.01 | 4.74 | |
| Current Ratio | 13.01 | 6.66 | 4.13 | 7.26 | 9.23 | 5.00 | |
| Return on Equity (ROE) | -96.89% | -127.64% | -115.16% | -7.99% | -429.55% | -535.72% | |
| Return on Assets (ROA) | -27.05% | -25.66% | -27.76% | -20.90% | -23.06% | -70.66% | |
| Return on Capital (ROIC) | -34.09% | -37.56% | -39.86% | -34.65% | -41.29% | -92.16% | |
| Earnings Yield | -12.75% | -16.42% | -32.83% | -1.23% | -9.98% | -45.48% | |
| FCF Yield | -8.72% | -15.53% | -29.26% | -12.50% | -3.49% | -42.03% | |
| Buyback Yield / Dilution | -76.20% | -3.57% | -0.59% | -35.24% | -34.19% | -18.78% | |
| Total Shareholder Return | -76.20% | -3.57% | -0.59% | -35.24% | -34.19% | -18.78% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.